Achim Moesta is an accomplished professional in the field of immunology and precision medicine, currently serving as Executive Director and Head of Oncology Precision Medicine at Regeneron since August 2023. Prior to this role, Achim held several leadership positions at Trishula Therapeutics, Inc., including Vice President and Executive Director of Immunology and Translational Sciences from August 2020 to August 2023. Achim’s previous experience also includes being Director of Immunology at Tizona Therapeutics, Inc., and holding senior scientist positions at Amgen, where contributions were made in Immuno-Oncology research. Academic foundations were built with a PhD in Immunology from Stanford University, complemented by a BA in Molecular Biology from Colgate University. Achim’s career reflects extensive expertise across various reputable organizations in the biotechnology sector.